Myelodysplastic Syndrome

When you have myelodysplastic syndrome, or MDS, you need the experience and expertise of a cancer center that is backed by cutting-edge research and that offers comprehensive care from a team of experts.

At Columbia Cancer, our highly experienced cancer care team is here to help you navigate every step of your journey.

Our Expertise at Your Service

At Columbia Cancer, our caregivers see hundreds of people with MDS each year. This is a rare, complex disease that has fewer than 15,000 people in the US diagnosed each year. So it’s even more important to choose a cancer center that has the right experts to help you.

We follow—and we’re creating—gold-standard care for myelodysplastic syndromes. You’ll have the benefit of working with doctors who may also be Columbia University researchers, in the lab and in clinical trials.

We’re backed by the power of the National Cancer Institute, which designated Columbia University as a Comprehensive Cancer Center, its highest designation.

Learn About Our Expertise

You’ll Receive State-of-the-Art Care

Columbia Cancer stands at the forefront of myelodysplastic syndrome (MDS) care and research.

Azra Raza, MD, director of the Columbia University MDS program, has been treating MDS patients for 30 years. She is a world leader in understanding and treating this disease.

We are a designated national Center of Excellence by the Myelodysplastic Syndromes Foundation. And we are a leader in MDS clinical trials and investigational therapies.